Patent assignee · US · COMPANY

Janssen BioPharma, Inc.

20Patents
20Active
20Granted
53Portfolio score

Filing activity: Mar 9, 2017 → May 23, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US10370401B2 Substituted nucleosides, nucleotides and analogs thereof Emerging Cross-Sectional Technologies 16 Active
US10487104B2 Substituted nucleosides, nucleotides and analogs thereof Chemistry; Metallurgy 4 Active
US10780105B2 Substituted nucleosides, nucleotides and analogs thereof Human Necessities 4 Active
US10745427B2 Acyclic antivirals Human Necessities 3 Active
USRE48171E1 Substituted nucleosides, nucleotides and analogs thereof General 3 Active
US10702523B2 AZA-pyridone compounds and uses thereof Chemistry; Metallurgy 3 Active
US10683320B2 Substituted nucleosides, nucleotides and analogs thereof Chemistry; Metallurgy 2 Active
US10696708B2 Substituted nucleosides, nucleotides and analogs thereof Chemistry; Metallurgy 2 Active
US10793591B2 Substituted nucleosides, nucleotides and analogs thereof Chemistry; Metallurgy 2 Active
US11180524B2 Modified nucleoside phosphoramidites Emerging Cross-Sectional Technologies 2 Active
US11021509B2 Substituted nucleosides, nucleotides and analogs thereof Chemistry; Metallurgy 1 Active
US11149049B2 Substituted nucleosides, nucleotides and analogs thereof Chemistry; Metallurgy 1 Active
US12030907B2 Modified nucleoside phosphoramidites Emerging Cross-Sectional Technologies 1 Active
US10793859B2 Modified oligonucleotides and methods of use Chemistry; Metallurgy 1 Active
US11312727B1 Macrocyclic flu endonuclease inhibitors Chemistry; Metallurgy 0 Active
US10980805B2 Aza-pyridone compounds and uses thereof Chemistry; Metallurgy 0 Active
US12428441B2 Modified nucleoside phosphoramidites Emerging Cross-Sectional Technologies 0 Active
US10905767B2 Oligonucleotide constructs and uses thereof Chemistry; Metallurgy 0 Active
US11014935B2 Compounds for the treatment of paramyxovirus viral infections Chemistry; Metallurgy 0 Active
US11021444B2 Antiviral compounds Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.